A two-tranche stock offering garnered approximately $7 million for Titan Medical. The proceeds will be used as working capital, as well as to advance the company's Sport robotic surgical system and support its general corporate functions.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.